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Prion diseases are closely linked to the conversion of host-encoded cellular prion protein (PrPC) into its pathological
isoform (PrPSc). PrP conversion experiments in scrapie infected tissue culture cells, transgenic mice, and cell-free systems
usually require unique epitopes and corresponding monoclonal antibodies (MAbs) for the immunological discrimination of
exogenously introduced and endogenous PrP compounds (e.g., MAb 3F4, which is directed to an epitope on hamster and
human but not on murine PrP). In the current work, we characterize a novel MAb designated L42 that reacts to PrP of a variety
of species, including cattle, sheep, goat, dog, human, cat, mink, rabbit, and guinea pig, but does not bind to mouse, hamster,
and rat PrP. Therefore, MAb L42 may allow future in vitro conversion and transgenic studies on PrPs of the former species.
The MAb L42 epitope on PrPC includes a tyrosine residue at position 144, whereas mouse, rat, and hamster PrPs incorporate
tryptophane at this site. To verify this observation, we generated PrP expression vectors coding for authentic or mutated
murine PrPCs (i.e., codon 144 encoding tyrosine instead of tryptophan). After transfection into neuroblastoma cells, MAb L42
did not react with immunoblotted wild-type murine PrPC, whereas L42 epitope-tagged murine PrPC was strongly recognized.
Immunoblot and fluorescence-activated cell sorting data revealed that tagged PrPC was correctly posttranslationally
processed and translocated to the cell surface. © 1999 Academic Press
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The accumulation of pathological prion protein (PrPSc) in
euronal tissue is a characteristic feature of all transmissi-
le spongiform encephalopathies (TSEs). Many experimen-
al data suggest that PrPSc represents the infectious agent
tself. PrPSc develops posttranslationally from a cellular pre-
ursor protein, PrPC, which is a membrane-bound protein
nd is predominantly expressed in neuronal cells of all
ammalian species studied to date (Basler et al., 1986).
he mouse PrP gene encodes for 254 amino acids (aa)
Locht et al., 1986). From the translation product, a signal
eptide of 22 residues is amino-terminally cleaved off, and
3 residues at the carboxyl-terminus are substituted by a
lycosylphosphatidylinositol (GPI) membrane anchor. In the
olgi apparatus, PrPC is N-glycosylated twice at aa 180 and
96, and cysteines at aa 179 and 213 are linked by a
isulphide bond (Prusiner, 1991).
The similarity in the aa sequence of donor PrPSc in
omparison to PrPC of the recipient species seems to
lay a crucial role in the species barrier. This has best
een shown for murine and hamster scrapie using mu-
ine experimental systems (e.g., transgenic mice, trans-
ected scrapie infected murine neuroblastoma cells, cell-
ree in vitro conversion assays) (Caughey et al., 1995,
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26989; Kocisko et al., 1994; Scott et al., 1989; Taraboulos et
l., 1990). These experiments were facilitated through the
vailability of monoclonal antibodies (MAbs), which im-
unologically allow the distinction of hamster and hu-
an PrPs from mouse PrP. These well characterized
Abs are directed to two epitopes on hamster PrP, one
f which encompasses aa 108–111, which is character-
zed by two methionines instead of a leucine and a valine
t the respective positions in mouse PrP (Barry et al.,
986, 1986; Kascsak et al., 1987; Rogers et al., 1991). The
rototype MAb to this epitope is MAb 3F4. The second
Ab epitope is located in the vicinity of aa 138 of PrP,
here mice incorporate isoleucine, whereas hamster
rP harbours methionine at this site. MAb 13A5 is the
rototype MAb to this site (Barry et al., 1986).
In a recent study, we introduced three novel MAb
pitopes of ruminant PrP (Harmeyer et al., 1998). MAbs
ere raised by immunization of PrP wild-type mice with
ynthetic peptide vaccines that were synthesized ac-
ording to the aa sequence of ovine PrP. Two of the three
evealed epitopes are located at the amino- and carbox-
l-termini of the proteinase K-resistant core fragment of
rPSc, whereas the third epitope was resembled by a
eptide spanning aa 145–163 of ovine PrP (correspond-
ng to codons 141–159 of murine PrP). The prototype
Ab to the latter domain has been designated MAb L42.
Because MAb L42 possesses unique binding features,
e characterized the corresponding PrP epitope in this
tudy. MAb L42 might provide an invaluable tool for the
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27CHARACTERIZATION OF NOVEL MAb EPITOPE ON PRION PROTEINSelection and characterization of transgenic mice ex-
ressing nonmurine PrP and might serve as a novel tag
or PrP conversion experiments in scrapie infected cell
ines and cell-free systems.
RESULTS
MAb L42 exhibits unique binding characteristics in
espect to its species-specific detection of prion pro-
eins. MAb L42 strongly reacts with metal affinity-purified
rPC of a broad range of species in immunoblotting;
hese species include sheep, cattle, goat, pig, human,
FIG. 1. Immunoblot detection of PrPCs of mammalian species. Im-
obilized metal affinity purified PrPC preparations of sheep, cow, goat,
ig, human, dog, cat, mink, rat, mouse, hamster, guinea pig, and rabbit
ere run on 13% polyacrylamide gels, electrotransferred onto Immo-
ilon P membranes, and probed with (a) MAb L42, which was raised by
mmunization with a synthetic peptide corresponding to aa 145–163 of
vine PrP (i.e., positions 141–159 of murine PrP) and (b) polyclonal
nti-peptide antibody Ra 18/4 from rabbit, which is directed to the
exapeptide repeat sequence of PrP. Although the polyclonal antibody
ross-reacted with PrPC of nearly all species, MAb L42 clearly detects
ll except murine, hamster, and rat PrPCs. Because the two blots were
oaded identically, the PrPC detection in the latter species by Ra 18/4
learly proves the presence of antigen. Because these antibodies were
aised in rabbits, they do not detect rabbit PrP. A similar immunotoler-
nce mechanism might apply for the missing detection of PrPC of
uinea pig. The numbers on the right side indicate the approximate
olecular masses as determined by marker proteins.
FIG. 2. Sequence alignment of the aa 141–159 of PrP of sheep, cow
ositions were calculated according to the murine PrP sequence. No
equence for guinea pig PrP is shaded because it is reported for the first timog, cat, mink, rabbit, and guinea pig (Fig. 1). Interest-
ngly, no reactivity is observed with PrPC of mouse, ham-
ter, and rat. This species-specific discrimination was
qually observed when PrPC was immunoprecipitated
rom crude brain tissue homogenate preparations and
ith immunoblotted PrPScs of scrapie susceptible spe-
ies (Harmeyer et al., 1998).
MAb L42 was raised by immunization of mice with an
ligopeptide covering the aa sequence 145–163 of ovine
rPC (corresponding to codon 141–159 of murine PrP).
mong the different species, three aa polymorphisms
re present in this region: position 142 N N S, position
44 Y N W, and position 154 Y N H N N (aa positions
alculated according to murine PrP) (Fig. 2). After com-
aring the reactivity of MAb L42 with the different PrPCs,
t became clear that the polymorphism at codon 144
orresponds with the immunoblotting and immunopre-
ipitation results: although most species express ty-
osine at this position, mouse, rat, and hamster incorpo-
ate tryptophan at this site.
Because PrPC from guinea pig, for which the aa se-
uence is unknown, also bound MAb L42, we assumed
hat this species also carries a tyrosine residue at this
rP position. This was verified after sequencing the cor-
esponding region of the PrP gene of guinea pig (Fig. 2).
We could further demonstrate via site-directed mutagen-
sis that the presence or absence of tyrosine or tryptophan
t aa position 144 of murine or PrPC of other species
odulates the binding of MAb L42. To introduce a tyrosine
t this site, the authentic open reading frame of murine PrP
as amplified by PCR using the half-genomic vector
PrPHG as a template. This vector contains major parts of
he prion gene of a s7s7 sinc genotype mouse. In a three-
tep PCR, a tyrosine-encoding sequence at codon 144 was
ntroduced by using two internal mismatch primers and two
xternal 59 and 39 primers, which were designed to provide
nique cleavage sites. PCR products representing either
he wild-type or mutated open reading frames were cloned
nto the vector pcDNA3.1/Zeo(1), which is particularly suit-
ble for the overexpression of exogenous PrPC in murine
euroblastoma (N2a) cells (Fig. 3). After sequencing of the
ig, human, mink, rat, mouse, hamster, guinea pig, and rabbit. The aa
polymorphisms among species at positions 142, 144, and 154. The, goat, p
te thee in this report.
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28 VORBERG ET AL.omplete PrP open reading frames, N2a cells were stably
ransfected with these vector constructs coding for either
ild-type or mutated murine PrPC. Transfected cells were
ubsequently cloned, and individual subclones were anal-
sed for their PrPC expression levels by immunoblotting
sing a rabbit polyclonal antibody against aa 94–109 of
urine PrP. Compared with normal neuroblastoma cells,
2a cells transfected with constructs coding for wild-type
r L42-tagged PrP strongly overexpressed PrP. Cell lysates
ere also analysed by immunoblotting for the presence of
he MAb L42 epitope. As predicted on the basis of the
equence data, MAb L42 strongly bound to the mutated
rPC epitope, whereas authentic murine PrPC was not de-
ected with the antibody (Fig. 4). In tagged murine PrP, MAb
42 stained all three bands, which represent the nonglyco-
ylated, monoglycosylated, and diglycosylated moieties of
he protein. To confirm the posttranslational translocation of
xogenous PrP to the membrane, transfected cells were
lso tested by fluorescence-activated cell sorting (FACS).
he incubation of living neuroblastoma cells expressing
ither tagged or untagged PrPC with MAb L42 revealed
inding of MAb L42 only to tagged PrPC. This shows that
ubstantial amounts of the L42 epitope-tagged murine PrPC
ere localized on the cell membrane, indicating that the
ost-Golgi translocation of newly synthesized protein was
nimpaired by the mutation (Fig. 5).
DISCUSSION
In this study, we characterized the novel MAb L42
pitope, which is present on PrPC of a broad range of
ammalian species (e.g., sheep, cattle, goat, pig, human,
og, cat, mink, rabbit, and guinea pig) but not on murine, rat,
nd hamster PrPC. In prion susceptible species, this dis-
riminatory feature of MAb L42 also applies to the corre-
ponding PrPScs. The MAb L42 epitope is located in the
icinity of aa 144 of murine PrP and requires the presence
f a tyrosine residue for antibody binding at this site. In
FIG. 3. Graphic illustration of the translation products in murine neu
moPrP and pmoPrPL42. The site of the aa exchange introducing tyros
osttranslational modifications: removal of the amino-terminal signal pe
ites, and the cleavage site for the substitution of the carboxyl-terminuontrast, a tryptophan residue at this site, as present in PrP bf mouse, hamster, and rat, clearly prevents antibody bind-
ng. We verified this result with site-directed mutagenesis of
urine PrPC (i.e., by substituting tryptophan by a tyrosine-
ncoding codon at this site). After this mutation and the
table expression of the gene product in murine neuroblas-
oma cells, MAb L42 strongly reacted with mutated murine
rPC in immunoblotted cell lysates. Recombinant L42
pitope-tagged PrP was authentically posttranslationally
toma cells transfected with the two pcDNA 3.1/Zeo(1)-based vectors
position 144 into murine PrP is shown as well as sites of subsequent
lack bars on the left), introduction of a disulfide bond, two glycosylation
bars on the right) by a GPI anchor sequence.
FIG. 4. Immunoblot detection of recombinant PrP, which was stably
xpressed in murine neuroblastoma cells. Immunoblotted cell lysates
ere probed using (a) a polyclonal anti-peptide antibody Ra 5/7 from
abbit to aa 94–109 of mouse PrP and (b) MAb L42. In the first lane, cell
ysate from control neuroblastoma cells was applied (WT). In the two
ollowing lanes, lysates from cells that were transfected with the ex-
ression vector pmoPrP coding for authentic murine PrP were sepa-
ated. In the fourth and fifth lanes, lysates from cells were probed that
tably express MAb L42 epitope-tagged murine PrP. Each lane dem-
nstrates subcloned cells of independent transfections. The number on
he right side assigns the approximate molecular mass as determinedroblas
ine at
ptide (by marker proteins.
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29CHARACTERIZATION OF NOVEL MAb EPITOPE ON PRION PROTEINSrocessed and, as FACS analysis revealed, translocated to
he cell surface.
MAb L42 therefore can be very useful as a discrimi-
atory antibody for the specific detection of exogenous
rPC and PrPSc in mice transgenic for prion genes of a
ariety of TSE-susceptible species, including human, cat-
le, goat, sheep, and mink, and thus will be made avail-
ble by the authors to scientists in the field who want to
ddress scientific questions. Moreover, this epitope can
e introduced into murine PrP by a single codon muta-
ion encoding a tyrosine residue at aa 144 and thus may
e used as a novel tag in in vitro PrP conversion assays
uch as scrapie infected murine neuroblastoma cells
nd cell-free systems. In the past, a variety of studies
sed the MAb 3F4 epitope to analyze the impact of aa
equence changes on the in vitro convertibility of PrPC.
owever, the introduction of this tag itself partially inter-
FIG. 5. FACS analysis of (a) neuroblastoma cells, (b) neuroblastoma
ells transfected with pmoPrP, and (c) pmoPrPL42. Wild-type N2a cells
nd stably expressing cell clones were incubated with MAb L42 and a
luorescent label, and the intensity of the labeled cells was determined
y FACScan (open areas). Cells incubated solely with the labeled
econdary antibody served as negative controls (filled areas). Note the
hift in stained cells that were transfected with the expression vector
oding for MAb L42 epitope-tagged PrP (pmoPrPL42).ered with the conversion process and substantially re- muced the total PrPSc accumulation in infected cells
Priola et al., 1994). Further investigations will therefore
ocus on whether the introduction of the L42 epitope into
urine PrPC has an impact on its convertibility in scrapie
nfected tissue culture cells and in transgenic mice. An-
ther MAb to this domain, designated MAb 6H4, has
een described recently (Korth et al., 1994); it is directed
o almost exactly the same region of PrP (aa 143–151).
owever, this MAb was raised in PrP-ablated mice and
acks the species specificity; it also reacts with murine
nd hamster PrP.
The three-dimensional structure of Escherichia coli
xpressed PrPC has recently been determined with NMR
nalysis (Billeter et al., 1997; Hornemann et al., 1997;
iek et al., 1996, 1997). According to these data, aa
panning 121–231 fold into a defined molecule that is
omposed of a two-stranded antiparallel b-sheet (aa
27–130, 160–163) and of three a-helices (143–153, 178–
92, 199–216), whereas aa 22–120 form a long, flexible
ail. According to the NMR model, the MAb L42 epitope
s located within the first a-helix of murine PrPC. In an
ttempt to better understand the immunogenicity and
ntigenicity of this domain, the predicted structure for
his defined region of PrPC was rotated in a computer
imulation so the stereoscopic location of the L42
pitope became visible. Most interestingly, this epitope
s located on the outbound turn of the first a-helix, with
he indolyl group of tryptophan protruding almost eccen-
rically from the molecular surface (Fig. 6). Such an ex-
osure is well in line with an enhanced immunogenicity
nd antigenicity of this domain; therefore, it is certainly
easible that the protruding side group of tryptophan at
osition 144 of murine PrPC is capable of blocking the
ccess of MAb L42 binding to its epitope. Tyrosine and
ryptophan, however, are very similar in their physico-
hemical characteristics: both are aromatic, hydropho-
ic, and polar residues. Together with the structural data,
his also suggests that a mutation of tryptophan into
yrosine at this site should not interfere with the overall
rPC structure.
MATERIALS AND METHODS
aterials
Murine neuroblastoma cells (purchased from Ameri-
an Type Culture Collection) were maintained in minimal
ssential medium containing nonessential aa supple-
ented with 10% FCS (GIBCO) and penicillin/streptomy-
in in an atmosphere of 5% CO2 at 37°C.
Polyclonal serum Ra 18/4 was raised in a rabbit
gainst a synthetic peptide conjugate covering the aa
equence according to codons 37–53 of murine PrP
RYPGQGSPGGNRYPPQG). Ra 5/7 polyclonal antibodies
ere raised in a rabbit against a murine PrP peptide that
orresponds to aa 94–109 (THNQWNKPSKPKTNLK). The
urine MAb L42 was raised against a synthetic peptide
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30 VORBERG ET AL.hat corresponds to the aa sequence 145–163 of ovine
rP (GNDYEDRYYRNMYRYPNQ).
The half-genomic murine PrP vector pPrPHG was
indly provided by Charles Weissmann (Eidgeno¨ssische
echnische Hochschule, Zu¨rich, Switzerland). The eu-
aryotic expression vector pcDNA3.1/Zeo(1) was pur-
hased from InVitrogen (Carlsbad, CA).
artial sequencing of the guinea pig PrP coding
egion
Brain tissue of guinea pig was used to isolate chro-
osomal DNA as described elsewhere (Sambrook et al.,
989). The DNA served as a template to amplify a
200-bp fragment of the PrP open reading frame with
he following oligonucleotide primers: 59-AACTACATGC-
GGGGAGCG-39 and 59-GTGGTAATAATGACCATGTG-39.
he sequence was confirmed by sequencing using an
BI Prism 377 DNA Sequencer (Perkin–Elmer Cetus,
FIG. 6. Stereoscopic analysis of the MAb L42 epitope. The three-
imensional structure of murine PrPC was based on previously published
ata (Billeter et al., 1997; Riek et al., 1996) that was retrieved from the
rookhaven Data Base and processed with the SYBYL program (Tripos
nc., St. Louis, MO). The aa backbone including side groups is shown.
llustrated by blue ribbons are the three a-helices spanning aa 143–153
right), 178–192 (left), and 199–216 (middle helix). As depicted in red, the
ndolyl side group of the aa tryptophan at position 144 protrudes eccen-
rically from the molecule and therefore presumably blocks murine PrPC
ccess to the MAb L42 epitope.oster City, CA). mrP constructs and transfection
The coding region as well as ;400 bp of the 39
ntranslated region (UTR) of wild-type mouse PrP was
mplified by PCR from the plasmid pPrPHG using the
ollowing primers: 59-TTGCCCTGCAGACTATCAGTCATC-
TGGCG-39, 59-GGCTGTTCTAGAGGGCGCCATCCC-39. A
utant PrP open reading frame coding for tyrosine in-
tead of tryptophan at aa 144 (numbering according to
urine PrP aa sequence) was generated by PCR overlap
utagenesis using mismatch primers 59-CCATTTTGGC-
ACGACTACGAGGACCGC-39 and 59-GCGGTCCTCGTA-
TCGTTGCCAAAATG-39 as well as the oligonucleotide
rimers described above. After cleavage with PstI and
baI, the PCR products were cloned into the expression
ector pcDNA3.1/Zeo(1). In this vector, inserted se-
uences are under control of the human cytomegalovirus
mmediate-early promoter/enhancer. The fidelity of each
onstruct was confirmed by sequencing.
Neuroblastoma cells were transfected using CaPO4
mammalian transfection kit; Stratagene, Amsterdam) ac-
ording to the manufacturer’s instructions. Antibiotic-re-
istant clones were selected in Zeozin (500 mg/ml; In-
itrogen)-supplemented media and subcloned once. Ex-
eriments were carried out on single cell lines
xpressing each construct.
reparation of cell lysates
Confluent cells were washed twice with PBS and lysed
n 0.32 M sucrose containing 0.5% deoxycholic acid and
.5% Nonidet P-40 for 10 min. Cell debris was pelleted
nd the supernatant was incubated with 10 mg/ml RNase
or 30 min at 37°C.
urification of cellular PrP
PrPC from brain tissue of all species was extracted and
urified using immobilized metal affinity chromatography as
escribed previously (Groschup et al., 1997; Pan et al.,
992). Briefly, brain tissues were homogenized with an
lectric homogenizer in PBS containing 0.32 M sucrose, 5
M PMSF, and 0.01 mg/ml N-tosyl-L-phenylalanine-chloro-
ethylketone (TPCK). Cell debris was pelleted at 3000g for
0 min at 4°C, and the supernatants were supplemented
ith polyethylene glycol (PEG 8000; Sigma) (4% w/v). Mi-
rosomes and membrane particles were precipitated for 15
in at 4°C, pelleted at 14,000g for 10 min, collected, and
esolubilized in PBS containing 5% Zwittergent (percent in
eference to the brain mass used), 5 mM PMSF, and 0.01
g/ml TPCK for 1 h at 4°C. The solutions were cleared of
emaining microsomal debris at 100,000g for 1 h at 4°C,
nd the detergent soluble proteins were applied to Cu21-
harged chelating Sepharose equilibrated with PBS con-
aining 0.2% Zwittergent and 0.5 M sodium chloride. Bound
roteins were eluted with PBS–Zwittergent containing 50
M EDTA. The eluate was dialysed against 0.05 M Tris–
H
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31CHARACTERIZATION OF NOVEL MAb EPITOPE ON PRION PROTEINSCl, pH 8.0, for 18 h, lyophilized, and resuspended in 1/33rd
f the initial volume.
DS–PAGE and immunoblotting
For electrophoretic separation on a 13% polyacryl-
mide gel, 0.53 sample buffer (2% SDS, 3% sucrose,
.001% bromphenol blue in 50 mM Tris–HCl, pH 7.4, 5%
ercaptoethanol) was added to the samples. After son-
cation for 30 s, samples were denatured for 5 min at
5°C, electrophoresed, and finally electrotransferred to
olyvinylpyrrolidone membranes (Immobilon P). Surplus
inding sites were blocked with 5% nonfat dry milk sol-
bilized in PBS supplemented with 0.1% Tween 20 for 30
in at room temperature (RT). Membranes were incu-
ated for 2 h at RT with either polyclonal rabbit serum
Ra18/4 at a dilution of 1:500 or Ra5/7 at a dilution of
:1500) or with monoclonal L42 hybridoma supernatant
t a dilution of 1:10 in blocking solution. Membranes
ere washed extensively in PBS containing 0.1% Tween
0 and thereafter incubated with horseradish peroxi-
ase-conjugated secondary antibody (Dianova, Ham-
urg, Germany) for 1 h. After a wash with PBS and 0.1%
ween 20, the blots were developed using the enhanced
hemiluminescence reagent system (Amersham) ac-
ording to the manufacturer’s instructions.
ACS analysis
Cells were washed twice with PBS and detached with
50 mM sucrose, 0.25 mM EGTA, and 0.25 mM EDTA in
ris–HCl-buffered solution, pH 7.8. After pelleting, the
ells were resuspended in PBS supplemented with 2%
CS and subsequently incubated with MAb L42 super-
atant for 30 min at 4°C. Cells were rinsed with PBS plus
% FCS and incubated with a 1:50 dilution of phyco-
rythrin-conjugated secondary antibody (Southern Bio-
echnology Associates) for an additional 30 min at 4°C.
ACS analyses of rinsed cells were carried out using a
ecton Dickinson FACStar Plus.
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